Recombinant baculovirus vaccine

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9023365
APP PUB NO 20100233202A1
SERIAL NO

12278916

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A recombinant transfer vector capable of expressing a foreign gene fused to a viral gene under the control of dual promoters and a recombinant baculovirus, and methods for production thereof, as well as pharmaceuticals comprising the recombinant baculovirus as an active ingredient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OTSUKA PHARMACEUTICAL CO LTDTOKYO
EDUCATIONAL FOUNDATION JICHI MEDICAL UNIVERSITY3311-1 YAKUSHIJI SHIMOTSUKE-SHI TOCHIGI 3290498

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Goto, Yoshihiro Tokushima, JP 96 1097
Hariguchi, Norimitsu Tokushima, JP 6 9
Kawasaki, Masanori Tokushima, JP 20 130
Matsumoto, Makoto Tokushima, JP 99 971
Mizukoshi, Masami Tokushima, JP 4 7
Ohba, Yoshio Tokushima, JP 4 8
Yoshida, Shigeto Shimotsuke, JP 44 556

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 5, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00